Proton Pump Inhibitor Lawsuit Lawyers

Free Case Evaluation

You Deserve Justice, and We Can Help You Achieve It

Use of proton pump inhibitor medications (commonly referred to as heartburn drugs) can lead to devastating injuries, including damage to the kidneys, complete loss of kidney function, and pancreatic cancer. Some proton pump inhibitor side effects will require invasive and ongoing medical treatment, and some can even lead to death.

It seems unthinkable that simple tablets, something you can buy at the grocery store, could be so dangerous, but many people have been permanently injured by these drugs. At Parker Waichman, LLP, we recognize the ways your PPI injuries have affected your life, and we understand how betrayed you feel by the pharmaceutical industry.

Why Choose Parker Waichman LLP for Your Claim?

When you have a claim against a billion-dollar pharmaceutical corporation, you need a skilled products liability law firm like Parker Waichman, LLP to simplify things the process for you. With only one quick phone call to Parker Waichman LLP, you will be preserving your legal right to file a claim.

In a drug product case like this, you need the best legal representation on your side. With our decades of experience in personal injury and product liability litigation, we have the skills and knowledge necessary to obtain the compensation you and your family need.

Near-unprecedented Results

Parker Waichman has secured near-unprecedented results for our clients, garnering more than $2 billion in settlement awards and verdicts.

Awards and Special Recognition

In our years of litigating personal injury and product liability cases, we have received numerous accolades and honors from fellow plaintiffs’ lawyers, defense lawyers, judges, and current and former clients. We are extremely proud of the reputation we have earned inside and outside the legal community, which includes receipt of the following honors:

  • 8 (out of a perfect 10) Rating by AVVO (a service that rates every attorney in the United States)
  • “Preeminent Lawyers” AV Peer Review Rating (Martindale-Hubbell® – a company that, for more than 100 years, has rated attorneys across the United States and the world based on feedback from judges and their peers)
  • Highest Ranking of “5 Dragons,” based on peer review by Lawdragon
  • Listing in Best Lawyers Publication, determined by Extensive Peer Review

Throughout the life of our national firm, we have earned the trust and respect of colleagues, judges, members of the community, and most importantly, clients. The attorneys and staff at Parker Waichman know you are working with us during a trying time, and we will be by your side every step of the way.

Free Case Investigation and Medical Review

We understand when you’re dealing with a potentially life-threatening PPI drug injury, you likely already have financial strain in your life from costly medical bills. That’s one of the reasons we offer consultations at no cost to you. The initial consultation is completely free, and we will investigate your claim with zero money up front. If our investigation concludes we cannot pursue a claim for you, you will never receive a bill from us.

No Fee Unless We Recover for You

And if we decide we can move forward, we will generally advance the costs of any claim we pursue on your behalf. We recognize the average person cannot afford to finance a product lawsuit, so we assume that financial risk and contract cases on a contingency fee basis. What this means is we only get paid if you get paid. If you do not receive an award from your lawsuit, you will not owe us a penny.

We Take on Big Corporations

Particularly in a proton pump inhibitor claim, where you are potentially suing one or more giant pharmaceutical manufacturers, the system can seem intimidating. But when you hire Parker Waichman, you can rest knowing we have the resources and experience to bring you the justice you deserve. We take on the biggest corporations and tackle the most complex cases.

We Will Hold Drug Manufacturers Accountable

Product liability cases can be complicated, particularly when you are up against giant pharmaceutical companies with fierce corporate counsel. Parker Waichman has extensive experience in handling these cases, and we know how to win. We are currently taking cases involving proton pump inhibitors, and the litigation is well underway.

We know when you sign your case with us, you are placing your trust in us, and we take that very seriously. We work tirelessly to obtain results for you and ease the burden placed on you and your family by these dangerous drugs. Our attorneys are invested in people and are committed to making the drug industry safer. Together, we can hold the drug manufacturers accountable for your injuries and help prevent the same from happening to others.

What Are Proton Pump Inhibitors (PPIs) Used For?

Heartburn can produce symptoms such as difficulty swallowing, tightness of the throat or chest, pain and burning in the chest and throat, regurgitation of food, and increased pain while lying down. The symptoms can become severe enough to interfere with people’s lives, and they turn to a physician or over-the-counter medication for relief.

PPIs have been shown to be effective in reducing or preventing heartburn symptoms because they inhibit the proton pump’s production of acid. Without the excess acid, patients’ gastric issues subside.

What Is the Problem With Proton Pump Inhibitors (PPis)?

Proton pump inhibitors (PPIs) are a class of drugs used to treat various gastric issues, the most of common of which is heartburn. PPIs are indicated for treatment of the following medical conditions:

  • Acid reflux
  • Chronic or occasional heartburn
  • Gastroesophageal reflux disease (GERD)
  • Barrett’s esophagus (an esophageal cell condition that can lead to cancer)
  • Dyspepsia
  • Gastritis (inflammation of the lining of the stomach)
  • Erosive esophagitis (esophageal tissue damage due to acid buildup)
  • Esophageal reflux disease
  • Eosinophilic esophagitis (inflammation of the esophagus due to an allergic reaction)
  • Peptic ulcer disease

The majority of people taking a daily PPI do so to prevent the painful symptoms of heartburn following a meal. After you eat, your stomach produces acid to aid the process of digestion. The acid is produced in a specific area, known as the “proton pump” or acid pump. Though the acid is beneficial for properly digesting food, it is also extremely powerful and corrosive. If you produce too much stomach acid, it can erode the lining of your stomach, cause painful ulcers, and creep up into the throat. Most people experience the effects of excess stomach acid as heartburn.

In addition to the damages that PPIs can inflict on adults, PPIs have also been linked to infectious bacterial diseases in children when paired with antibiotic treatments, sometimes resultng in death. For more information, read Parker Waichman’s coverage of a brand new case review study that was released on April 3, 2019 here.

Over One-third of Older Americans May Be Taking Medications They Do Not Need

(09/06/2019) CALIFORNIA – One recent study has found that as many one-third or more of Americans over the age of 65 may be taking medications for far longer than is necessary. Proton pump inhibitors like Nexium and Prilosec are utilized to address gastric ulcers and bleeding in the gastrointestinal system due to the effects of some blood thinners. Rather than taking these proton pump inhibitor drugs for a fixed duration (eight weeks being the most common course of treatment), a full one-third of older Americans studied may be taking these drugs for far longer, thereby putting their health at greater risk.

Findings of the Study

The 2018 study reported on in the Journal of the American Geriatrics Society looked at nearly 9,000 Americans who were over the age of 65 and who had been prescribed a proton pump inhibitor drug. From this group, researchers focused in on a group of about 400 individuals as a sample group. Researchers discovered that while many people in the group started out by utilizing proton pump inhibitor drugs in an appropriate way, by the end of the study over 35 percent of individuals were continuing to be prescribed proton pump inhibitors despite the drugs no longer being necessary or appropriate for such individuals to continue taking.

Who is to Blame? Patients or Doctors?

The elderly can experience infections and other serious health consequences from taking proton pump inhibitors for too long. Patients may forget how long they have been taking the drugs or may not realize that they may not need to take the drugs indefinitely. Similarly, doctors’ records may not be sufficiently complete or up-to-date to recognize when a patient has taken such drugs for too long of a period. Improvements in both patient education, medical recording practices, and medical care can all help in reducing the incidence of these drugs being over-prescribed and overused.

FDA Reports Cancer-Causing Agents Found in Zantac

September 19, 2019 – WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) released a statement regarding concerns the agency harbors regarding the potential of a cancer-causing agent, n-nitroso dimethylamine, known as NDMA, found in Zantac. The FDA warned patients that NDMA could cause cancer in humans. However, the FDA believes that NDMA found in ranitidine exists in low-levels. The agency said that it would continue to test ranitidine-based medicines with an eye toward reaching a conclusion about the potential risk to public health ranitidine presents.

The FDA said that NDMA is a chemical that exists in the environment and is present in most of the foods we consume. The FDA announced that NDMA exists in our water supplies, certain meats, vegetables, dairy goods, and other food products we consume in the U.S. The levels of NDMA the FDA found in ranitidine samples is slightly higher than the levels found in everyday foods we consume.

The FDA is taking a measured approach toward resolving this issue. The agency stopped short of demanding a recall of Zantac and all other ranitidine-based medicines, but researchers will continue to examine the potential effects of NDMA consumption.

The FDA previously demanded a recall of certain high blood pressure and heart disease medications due to excessive levels of NDMA. The FDA found that those medications recalled contained a dangerously high level of NDMA. The levels of NDMA in ranitidine do not appear to be as high as those found in the recalled blood pressure and heart medications.

Notwithstanding the seemingly relaxed approach taken by the FDA, the agency cautions patients that medications are on the market, which can help control heartburn and acid reflux that does not contain ranitidine. FDA scientists recommend that patients taking prescription Zantac should discuss changing medications with their doctors. Also, people taking over-the-counter ranitidine products should select alternative treatments.

Anyone who experiences adverse effects from NDMA found in ranitidine should file a report with MedWatch.

Proton Pump Inhibitor Brand Names

A large array of PPIs is currently on the market — both prescription and non-prescription — to treat the above conditions. The most commonly known names of

PPIs include:

  • Prilosec (omeprazole)
  • Nexium (esomeprazole)
  • Prevacid (lansoprazole)
  • Protonix (pantoprazole)
  • Zegerid (omeprazole)
  • Aciphex (rabeprazole)
  • Dexilant (dexlansoprazole)

As you can see, all of the chemical names for these PPIs end in the suffix “-prazole,” which makes them easier to identify. But the most widely recognized names are undoubtedly Prilosec, Nexium, and Prevacid. Not only have these drugs been on the market for a long time, they have also undergone major consumer advertising to turn them into household names. And while many people do find relief from certain gastric symptoms using these drugs, they unfortunately are also at risk for serious side effects.

PPI Drug Side Effects and Injuries

Despite what most people think, PPIs are not intended to be daily, long-term-use drugs. PPIs are supposed to be taken during a temporary and short period of time (about 14 to 30 days) and withdrawn to see if the gastric symptoms have been remedied without need for continued medication. When taken daily and throughout the course of many years, PPIs can cause serious, permanent side effects.

In our experience litigating PPI cases, our clients have reported the following injuries:

Kidney Injury

A sudden injury to the kidney that results in reduced kidney function. This can be characterized by fatigue, difficulty sleeping or concentrating, swelling in the legs and feet, muscle cramps, and reduced urine output.

Acute Interstitial Nephritis (AIN)

An abrupt deterioration in kidney function due to inflammation and edema of the renal interstitium. AIN can cause decreased urinary output, fever, blood in the urine, confusion, fatigue, vomiting, rash, changes in blood pressure, and swelling in the legs and feet.

Chronic Kidney Disease

A persistent impairment of the kidneys that leads to kidney failure. Chronic kidney disease is characterized by many of the same symptoms as kidney injuries and AIN and is usually diagnosed in stages ranging from 1 to 5. Stage 5 chronic kidney disease is essentially kidney failure.

End-stage Renal Disease

Ongoing reduced kidney function such that the patient requires a kidney transplant or dialysis to survive.

Renal Failure

Complete impairment of the kidneys such that the patient requires frequent (sometimes daily) dialysis to survive and will most likely need an immediate kidney transplant.

Pancreatic Cancer

As with many cancers, the precise cause of pancreatic cancer remains unclear, but recent studies show a correlation between PPI use and the development of pancreatic conditions, including pancreatic cancer.

Proving Liability for Your Kidney Injury

In the cases of kidney injury and AIN, patients’ problems generally resolve after withdrawing their PPIs. However, because many of the symptoms are so vague and mimic other commonplace issues — like the flu, dehydration, and side effects of stress — it can be extremely difficult to get a diagnosis. The most effective way to diagnose these conditions is through blood work and biopsies that will show changes in your creatinine levels and damage to the kidneys. Biopsies are quite invasive, though, so many doctors opt for more conservative treatment if they are clued into the decrease in kidney function at all.

Both kidney injury and AIN can lead to chronic kidney disease, end-stage renal disease, renal failure, and the need for dialysis and transplant. Once kidney damage has advanced to a certain point, withdrawing the PPI is not enough. The patient at that point is faced with a lifelong medical complication and the potential for operations and even death.

Your kidneys are absolutely vital to healthy physical function, as they filter out chemicals and waste from your body. PPIs can damage your kidneys, leaving them unable to expel harmful materials from your body.

Why are so many people taking these drugs every day for years and years if the drugs are this dangerous? The answer is intense marketing, accessibility, and a failure by PPI manufacturers to warn doctors and consumers about the risks of taking these drugs.

Prescription Marketing and the Emergence of an Over-the-counter Option

The first PPI to be approved for sale on the market was Prilosec (manufactured by AstraZeneca) in 1989. Prilosec and its early competitors were initially available only through prescription, but the manufacturers strongly pushed their drugs into the hands of doctors and thereby consumers. And seeing an enormous potential in the market, AstraZeneca was also the first to gain approval for an over-the-counter alternative to prescription Prilosec, through a partnership with Proctor & Gamble Co. The FDA approved Prilosec OTC (omeprazole magnesium) in June 2003.

The early 2000s saw a swift and aggressive flood of PPI consumer advertising, all touting the ease and convenience of picking up your favorite heartburn preventative in the same place you buy groceries. And this advertising was stunningly effective. By 2016, an estimated 15 million Americans were taking a PPI.

Unnecessary PPI Use and Prolonged Overuse

A huge problem with this is, when manufacturers eliminate physician oversight, people can misdiagnose themselves, grab the wrong medication off the store shelf, and take that medication too often and for too long. Studies suggest that potentially 70 percent of people taking a PPI do not have an appropriate indication for ingesting the medication. Studies further show that a significant percentage of the people taking PPIs are taking them far too long. These medications should only be taken for about two weeks, but people are using them for years, sometimes decades, which puts them at great risk of serious side effects.

Marketing Messages Imply PPIs Are Harmless

Why do people have the misconception that PPIs are safe to take, and actually should be taken, every day indefinitely? Think about a PPI commercial you’ve seen lately. You likely remember Larry the Cable Guy zooming across your television telling you to “take one a day for zero heartburn!” or “take one each morning for frequent heartburn.” He even talks about how taking Prilosec every day eliminates stomach acid, rather than waiting until you get heartburn and taking something else to treat it. It definitely sounds like this is a medication you should take every single day, long-term, to prevent heartburn.

Over-the-counter PPIs Lack the Same Warning Information as Prescriptions

And while the prescription drug labels for PPIs are lacking in warning information about pancreatic cancer and kidney damage, the over-the-counter packaging is even worse. Almost none of the prescriptions’ side effects and warnings appear on the over-the-counter boxes. Moreover, even though the drug labels and the over-the-counter boxes say the drug should be taken for 14 to 30 days, they do not tell doctors, patients, and consumers what could happen if they take it longer. PPI manufacturers have simply not adequately communicated how these drugs should be taken.

For these reasons, Parker Waichman is going after the manufacturers to hold them accountable and see change within the industry. Too many people have been injured, and too many consumers are still in the dark. If you have taken a PPI and developed pancreatic cancer or kidney damage, contact our office today to see if you might qualify for a lawsuit.

Statute of Limitations Considerations

Statutes of limitations are imposed by all states to place time restraints on filing lawsuits. These limitations operate to completely bar a person’s claim if it is not filed in the appropriate amount of time within the appropriate court. While that can seem harsh, states enact statutes of limitations to encourage people to act quickly after an injury, the theory being that swifter action results in higher-quality evidence for trial. In example, your memory of a certain event will be much stronger and more reliable one year after it happens versus 10 years after it happens. Filing a lawsuit sooner also increases the likelihood that medical records and business documents will still be intact and retrievable. Additionally, states do not want to place potential defendants in situations where they have to anticipate lawsuits forever. At some point, the potential for a claim needs to expire.

Every state sets its own individual statute of limitations on every type of legal claim, and they can vary greatly. For instance, the state of Missouri has a two-year statute of limitations on medical malpractice claims but a five-year statute of limitations on product liability claims. Calculating the statute incorrectly can be extremely costly.

Parker Waichman is a national law firm. Each state has a different statute of limitations for product liability actions.

Discovery Rules

Some states have what are called “discovery rules” that relax the statutory time limitations by allowing the clock to only begin running after a person discovers that he has been injured and, sometimes, also after he discovers — or has reason to discover — why he was injured and by whom he was injured.

Factors in Determining the Time You Have to File a Lawsuit

Many factors go into calculating the statute of limitations on a person’s case. The only way to definitively determine the correct statute of limitations on your potential PPI claim is to work with an experienced lawyer, like the lawyers at Parker Waichman LLP. When we sign up a case, we immediately go to work pinning down the appropriate statute of limitations and preserving all relevant evidence to make sure we have time to file a lawsuit and have everything we need to build the best possible case. If you suffered an injury after taking a PPI, contact our office today.

Am I Eligible to File a Lawsuit?

Statute of Limitations Considerations Depends on State

The only way to find out whether you can file a lawsuit against the manufacturer of a PPI is to retain a skilled drug product lawyer to investigate your potential case. Though the PPI litigation is far-reaching, there is a set of basic criteria a case must meet before it can move forward.

At Parker Waichman, we know how important it is for you to have an answer as to your potential case quickly. When you hire our accomplished legal team, we will immediately begin the process of reviewing your claim to determine the next possible steps.

Our case investigation will begin by performing the following tasks on your behalf:

  • Obtaining a detailed account of your PPI use history and the injuries you suffered while taking the drug or after you stopped taking the drug;
  • Ordering pharmacy records or medical records that document your use of a PPI and identify who manufactured the PPI you took (which we call establishing “proof of use”);
  • Ordering records documenting your PPI injury diagnoses and the treatment you received related to your PPI injuries;
  • Identifying the governing statute of limitations for your claim (the state-determined time during which you must file your lawsuit);

If this preliminary investigation determines you have a viable claim, we will move to the next phases of your claim, which will include all of the following:

  • Consulting with medical experts and industry experts to obtain support for your claim;
  • Determining where your case should be filed (whether in Multidistrict Litigation or elsewhere);
  • Drafting and preparing a petition for filing;
  • Completing written discovery or Plaintiff Profile Forms/Plaintiff Fact Sheets;
  • Reviewing electronic and written discovery from the defendants;
  • Conducting or reviewing depositions;
  • Participating in court hearings;
  • Meeting court-ordered deadlines;
  • Exchanging records with the defendants;
  • Participating in potential settlement negotiations; and
  • Carrying out any possible settlement program applicable to your claim.

When you work with the dedicated attorneys at Parker Waichman, you will always be kept in the loop on the progress of your case and the progress of the general PPI litigation. We want to make sure you always understand what is going on and feel confident about where your case is headed. Our team will be by your side the whole way, and we will work together toward the best possible resolution for you and your family.

Building a successful drug product case takes time and hard work, and it is never too early to start. If you think you might have a PPI case, contact Parker Waichman today.

Frequently Asked Questions About PPIs and Kidney Injuries

If this preliminary investigation determines you have a viable claim, we will move to the next phases of your claim, which will include all of the following:

  • Prilosec (omeprazole)
  • Nexium (esomeprazole)
  • Prevacid (lansoprazole)
  • Protonix (pantoprazole)
  • Zegerid (omeprazole)
  • Aciphex (rabeprazole)
  • Dexilant (dexlansoprazole)

As you can see, all of the chemical names for these PPIs end in the suffix “-prazole,” which makes them easier to identify.

The majority of people taking a daily do so to prevent the painful symptoms of heartburn following a meal. Your stomach produces acid to aid the process of digestion after you eat. The acid is produced in a specific area, known as the “proton pump” or acid pump. Though the acid helps your body properly digest food, it is also extremely powerful and corrosive. If you produce too much stomach acid, it can erode the lining of your stomach, cause painful ulcers, and creep up into the throat. Most people experience heartburn related to this excess acid.

Heartburn can produce symptoms such as difficulty swallowing, tightness of the throat or chest, pain and burning in the chest and throat, regurgitation of food, and increased pain while lying down. The symptoms can become severe enough to interfere with people’s lives, and they turn to a physician or over-the-counter medication for relief. PPIs have been shown to be effective in reducing or preventing heartburn symptoms because they inhibit the proton pump’s production of acid. Without the excess acid, patients’ gastric issues subside.

When taken daily and throughout the course of many years, PPIs can cause serious, permanent side effects. In our experience litigating PPI cases, we have had clients report the following injuries:

  • Kidney injury – A sudden injury to the kidney that results in reduced kidney function. This can be characterized by fatigue, difficulty sleeping or concentrating, swelling in the legs and feet, muscle cramps, and reduced urine output.
  • Acute interstitial nephritis (AIN) – An abrupt deterioration in kidney function due to inflammation and edema of the renal interstitium. AIN can cause decreased urinary output, fever, blood in the urine, confusion, fatigue, vomiting, rash, changes in blood pressure, and swelling in the legs and feet.
  • Chronic kidney disease – A persistent impairment of the kidneys that lead to kidney failure. Chronic kidney disease is characterized by many of the same symptoms as kidney injuries and AIN and is usually diagnosed in stages ranging from 1 to 5. Stage 5 chronic kidney disease is essentially kidney failure.
  • End-stage renal disease – Ongoing reduced kidney function such that the patient requires a kidney transplant or dialysis to survive.
  • Renal failure – Complete impairment of the kidneys such that the patient requires frequent (sometimes daily) dialysis to survive and will most likely need an immediate kidney transplant.
  • Pancreatic cancer – As with many cancers, the precise cause of pancreatic cancer remains unclear, but recent studies show a correlation between PPI use and the development of pancreatic conditions, including pancreatic cancer.

In the cases of kidney injury and AIN, patients’ problems generally resolve after withdrawing their PPIs. However, because many of the symptoms are so vague and mimic other commonplace issues — like the flu, dehydration, and side effects of stress — it can be extremely difficult to get a diagnosis. The most effective way to diagnose these conditions is through blood work and biopsies that will show changes in your creatinine levels and damage to the kidneys. Biopsies are quite invasive, though, so many doctors opt for more conservative treatment if they are clued into the decrease in kidney function at all.

Both kidney injury and AIN can lead to chronic kidney disease, end-stage renal disease, renal failure, and the need for dialysis and transplant. Once kidney damage has advanced to a certain point, withdrawing the PPI is not enough. The patient at that point is faced with a lifelong medical complication and the potential for operations and even death.

Statute of Limitations Considerations Depends on State

Because so many PPI cases are pending and so many manufacturers are involved, all of the PPI cases have been centralized in one court in the U.S. District Court for the District of New Jersey in what is called a Multidistrict Litigation (MDL). The MDL court oversees all the cases to ensure uniformity of decision in pretrial matters. MDLs help to prevent duplicate work and conserve resources for all parties involved.

More than 200 cases were pending in the Proton Pump Inhibitor MDL as of September 2017 in front of U.S. District Judge Claire C. Cecchi. The formation of this MDL was hard-fought. Plaintiffs first requested an MDL and transfer of nearly 40 cases pending in more than 20 different states in October 2016. In February 2017, however, the Judicial Panel on Multidistrict Litigation (JPML) denied plaintiffs’ application. But plaintiffs’ counsel persisted and moved once again for an MDL and transfer order in May 2017. The JPML approved their renewed motion a few months later.

The MDL court will preside over the first PPI trials, called “bellwether trials.” During the bellwether process, a small selection of cases pending in the MDL will be completely worked up for trial and eventually tried before a real jury. Before these trials take place, plaintiffs’ counsel and defense counsel will conduct discovery, including written interrogatories and depositions, and will attend multiple hearings with the judge to sort through discovery and expert matters. The bellwether trials sometimes jumpstart settlement negotiations but should not be taken as a sure sign of results either way.

The PPI litigation is unique in the sense that many plaintiffs will have taken multiple brands and switched from prescription PPIs to over-the-counter PPIs. Given the likelihood of switching while trying to find the drug that works best, we expect that our PPI clients will often come to us not knowing for sure what they took and when they took it. However, in order to file a lawsuit against a particular manufacturer, we have to be able to present evidence you used that manufacturer’s product.

That said, you don’t need to worry if you do not remember the names of all your medications. We will do that investigation for you. When you hire Parker Waichman, we will order your pharmacy records right away to determine what PPI brands you took and who manufactured them. Even if your records do not show the exact name of the drug, we can track down National Drug Codes (NDCs) from your pharmacies to prove what medications you took and when. And though it is difficult to trace over-the-counter purchases, we will do everything we can to identify the PPIs you used and build a viable case against the right manufacturers.

The U.S. Food and Drug Administration (FDA) has not recalled any PPI drugs to date. It has issued several warnings about PPIs, but these are unrelated to the kidney injuries and pancreatic cancer that are the subject of the current PPI litigation.

For instance, in May 2010, the FDA issued a Safety Announcement stating that it was requiring a label change for over-the-counter PPIs to include new safety information about a possible increased risk of fractures of the hip, wrist, and spine. However, in March 2011, the FDA then updated this Announcement to state that a warning as to fractures was actually not necessary at the time. It had concluded after a through review that fractures were unlikely with use of over-the-counter PPIs.

Interestingly, the updated Announcement included a caution about patients taking over-the-counter PPIs too long: “FDA acknowledges that consumers, either on their own or based on a healthcare professional’s recommendation, may take these products for periods of time that exceed the directions on the OTC label.” This means that at least by 2011, both the FDA and manufacturers were aware of a problem with people taking PPIs for longer periods of time than intended.

If PPIs have the potential to cause such serious harm, why are doctors continuing to prescribe them? There is not a simple answer to this question, but we know a large reason physicians started to and continue to prescribe proton pump inhibitors to their patients is rooted in the information disseminated to them by the manufacturers.

Believe it or not, a huge portion of the information doctors know about a drug comes directly from the manufacturer. When new drugs come on the market, it is the manufacturer’s job to get them into the hands of consumers. The only way to do that is through doctors (unless you come up with an over-the-counter option, too). As sales representatives are trying to make sales, they often do not share the whole truth. And if risk information is not even in the drug labeling, doctors have no way of knowing about it and providing that information to patients.

Included in the allegations Parker Waichman details in our PPI lawsuits are failure to warn doctors about the risks associated with PPI use and failure to provide doctors with updated information about risks and reported complications. For decades, PPI manufacturers have deprived people of the ability to make informed decisions about their medical treatment, and we are fighting to make them pay for that injustice.

The attorneys at Parker Waichman are committed to helping you receive appropriate compensation for your PPI injuries. By filing a claim against the manufacturer of the PPI you took, you can recover for all the ways your injury has affected your life. This includes money damages for the following:

  • Medical bills
  • Future medical bills
  • Lost wages
  • Future lost wages
  • Loss of Consortium (a special claim to collect for the ways your injuries have affected your marriage)
  • Physical and mental pain and suffering
  • Punitive damages

When you hire our firm, we will do everything we can to maximize your recovery by working with you to understand the complete and full extent of your damages. We will total medical bills, obtain tax returns and W2s to show the income you have lost and make sure we understand exactly how your PPI injuries interfere with your life every day. If found liable, the drug manufacturer needs to pay you for every way you have been affected.

At this stage of the PPI lawsuits, we are not able to make determinations about the duration of the litigation. It is also very important to note that settlements are never guaranteed. While we will fight tenaciously for your case to be resolved, we can never be 100 percent sure of what the defendants will do.

As you can imagine, many people have been affected by PPI injuries. Because of the potential for this litigation to be extremely large, things might tend to move more slowly than a standard personal injury claim. MDL management sometimes moves slower than state court cases, though there are multiple reasons to favor an MDL over a state court action in a litigation of this size. Throughout the entire time your case is pending, we will always do our best to keep you updated on the litigation’s progress. And we are always a phone call or email away. Any time you have questions about how your case is going, we are happy to answer those and strive to do so in a timely fashion.

You have legal rights, and we can help you protect them. Our experienced drug product lawyers are ready to start the process of investigating your potential claim. If you or a loved one took a proton pump inhibitor and developed a kidney injury, kidney failure, or pancreatic cancer, contact our firm today by filling out our online form or by calling 1-800-YOURLAWYER (1-800-968-7529) for a free consultation.

Get Your Free Case Evaluation

Free Case Evaluation

Our locations

  • New York
    59 Maiden Lane, 6th Floor
    New York, New York 10038
    +1 212-267-6700
  • Long Island
    6 Harbor Park Drive
    Port Washington, New York 11050
    +1 516-466-6500
  • Brooklyn
    300 One Pierrepont Plaza, 12th Floor
    New York, New York 11201
    +1 718-469-6900
  • Queens
    118-35 Queens Boulevard, Suite 400
    Forest Hills, New York 11375
    +1 718-469-6900
  • New Jersey
    80 Main Street, Suite 265
    West Orange, New Jersey 07052
    +1 973-323-3603
  • Florida
    27300 Riverview Center Boulevard, Suite 103
    Bonita Springs, Florida 34134
    +1 239-390-1000